Ireland· IE-PA-PA2028/001/001
Cleenema Ready-to-Use 21.4 g/9.4 g Enema
A sodium phosphate product containing sodium dihydrogen phosphate dihydrate + disodium phosphate dodecahydrate, registered in Ireland by Casen-Recordati S.L.. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Sodium phosphate is registered in 8 of 19 countries.
Countries holding a registration under ATC A06AG01 (sodium phosphate), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Sodium phosphate · ATC A06AG01
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Sodium dihydrogen phosphate dihydrate + Disodium phosphate dodecahydrate
- Manufacturer
- Casen-Recordati S.L.
- Country
- Ireland (IE)
- ATC code
- A06AG01
- ATC class
- Sodium phosphate
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2028/001/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium phosphate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyNatriumphosphat BraunB.Braun Melsungen Ag
- CzechiaCASINEMACasen Recordati, S.L., Utebo, Zaragoza
- FinlandPhosphoralCasen Recordati, S.L.
- NorwayPhosphoralCasen Recordati, S.L
- SwedenPhosphoral 24,4 g/10,8 g Oral lösningCasen Recordati, S.L.
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Belgium · Cleen Enema, Cleen Enema Pediatric
- Cyprus · Cleenema, Enema Flex Phosphates
- Czechia · Ardeaelytosol Conc. Natriumhydrogenfosfát, Casinema
- Germany · Natriumphosphat Braun, Phospho-Soda
- Denmark · Cleenema Klar-Til-Brug, Fosfat Sad
- Spain · Fosfoevac, Fosfosoda
- Finland · Phosphoral
- France · Normacol Lavement Adultes, Normacol Lavement Enfants
- United Kingdom (Northern Ireland) · Cleen Ready-To-Use, Fletchers' Phosphate
- Greece · Dulox, Enema Flex Phosphates
- Hungary · Casinema, Phospho-Soda
- Italy · Clisma Fleet, Sodio Fosfato Afom
- Luxembourg · Cleen Enema, Cleen Enema Pediatric
- Malta · Sodium Phosphate Sella
- Netherlands · Cleenema, Phosphoral
- Norway · Phosphoral
- Portugal · Phospho-Soda, Preclint
- Sweden · Phosphoral
- Slovakia · Cleenema
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/44b90912-bb13-4694-8dae-1e62051bb5be GET /v1/drugs/44b90912-bb13-4694-8dae-1e62051bb5be?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Rectal solution",
"routes": [
"Rectal use"
],
"source": "hpra",
"atc_all": [
"A06AG",
"A06AG01"
],
"strength": null,
"pa_number": "PA2028/001/001",
"substances": [
"Sodium dihydrogen phosphate dihydrate",
"Disodium phosphate dodecahydrate"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "16/02/1995",
"dispensing_status": "Product not subject to medical prescription",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about sodium phosphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.